John Grant

John Grant is a seasoned business development professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Senior Vice President of Business Development at Perspective Therapeutics, John focuses on pioneering Pb212 radiopharmaceuticals for cancer treatment. Previously, John held leadership roles at Garuda Therapeutics and Albireo Pharma, where major achievements included establishing business development functions and executing multiple partnerships to enhance asset value. John's career also encompasses significant contributions at Intellia Therapeutics, ARIAD Pharmaceuticals, and Millennium Pharmaceuticals, where strategic negotiations and innovative licensing agreements led to expansion and collaborative success in oncology and cell therapy. With a PhD in Molecular Biology from The University of Edinburgh and a background in consulting, John continuously drives growth and partnerships across the life sciences industry.